Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrew W McFadden

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Current Topics in Developmental Biology|October 24, 2007
Genetic manipulation of megakaryocytes to study platelet functionJun Liu, Jan DeNofrio, Weiping Yuan, et al.
Cancer Research|January 14, 2010
Identification of the receptor tyrosine kinase c-Met and its ligand, hepatocyte growth factor, as therapeutic targets in clear cell sarcomaIan J Davis, Andrew W McFadden, Yixiang Zhang, et al.
Molecular and Cellular Biology|September 20, 2006
CIB1 is essential for mouse spermatogenesisWeiping Yuan, Tina M Leisner, Andrew W McFadden, et al.
Genome Research|November 17, 2011
Tumor-specific retargeting of an oncogenic transcription factor chimera results in dysregulation of chromatin and transcriptionMukund Patel, Jeremy M Simon, Michael D Iglesia, et al.
The Journal of Biological Chemistry|July 11, 2018
PBRM1 bromodomains variably influence nucleosome interactions and cellular functionMariesa J Slaughter, Erin K Shanle, Andrew W McFadden, et al.
Circulation Research|November 3, 2007
CIB1 regulates endothelial cells and ischemia-induced pathological and adaptive angiogenesisMohamed A Zayed, Weiping Yuan, Tina M Leisner, et al.
The Journal of Cell Biology|January 19, 2006
CIB1 is an endogenous inhibitor of agonist-induced integrin alphaIIbbeta3 activationWeiping Yuan, Tina M Leisner, Andrew W McFadden, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 2, 2016
High-throughput small molecule screen identifies inhibitors of aberrant chromatin accessibilitySamantha G Pattenden, Jeremy M Simon, Aminah Wali, et al.
Molecular Cancer Research : MCR|July 5, 2014
PTEN deficiency mediates a reciprocal response to IGFI and mTOR inhibitionMukund Patel, Nicholas C Gomez, Andrew W McFadden, et al.
Frontiers in Oncology|February 16, 2023
MS0621, a novel small-molecule modulator of Ewing sarcoma chromatin accessibility, interacts with an RNA-associated macromolecular complex and influences RNA splicingTamara Vital, Aminah Wali, Kyle V Butler, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Current Topics in Developmental Biology|October 24, 2007
Genetic manipulation of megakaryocytes to study platelet functionJun Liu, Jan DeNofrio, Weiping Yuan, et al.
Cancer Research|January 14, 2010
Identification of the receptor tyrosine kinase c-Met and its ligand, hepatocyte growth factor, as therapeutic targets in clear cell sarcomaIan J Davis, Andrew W McFadden, Yixiang Zhang, et al.
Molecular and Cellular Biology|September 20, 2006
CIB1 is essential for mouse spermatogenesisWeiping Yuan, Tina M Leisner, Andrew W McFadden, et al.
Genome Research|November 17, 2011
Tumor-specific retargeting of an oncogenic transcription factor chimera results in dysregulation of chromatin and transcriptionMukund Patel, Jeremy M Simon, Michael D Iglesia, et al.
The Journal of Biological Chemistry|July 11, 2018
PBRM1 bromodomains variably influence nucleosome interactions and cellular functionMariesa J Slaughter, Erin K Shanle, Andrew W McFadden, et al.
Circulation Research|November 3, 2007
CIB1 regulates endothelial cells and ischemia-induced pathological and adaptive angiogenesisMohamed A Zayed, Weiping Yuan, Tina M Leisner, et al.
The Journal of Cell Biology|January 19, 2006
CIB1 is an endogenous inhibitor of agonist-induced integrin alphaIIbbeta3 activationWeiping Yuan, Tina M Leisner, Andrew W McFadden, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 2, 2016
High-throughput small molecule screen identifies inhibitors of aberrant chromatin accessibilitySamantha G Pattenden, Jeremy M Simon, Aminah Wali, et al.
Molecular Cancer Research : MCR|July 5, 2014
PTEN deficiency mediates a reciprocal response to IGFI and mTOR inhibitionMukund Patel, Nicholas C Gomez, Andrew W McFadden, et al.
Frontiers in Oncology|February 16, 2023
MS0621, a novel small-molecule modulator of Ewing sarcoma chromatin accessibility, interacts with an RNA-associated macromolecular complex and influences RNA splicingTamara Vital, Aminah Wali, Kyle V Butler, et al.
Pageof 1